Try our Advanced Search for more refined results
May 13, 2014
Medicines Company v. Hospira, Inc.
Case Number:
14-1469
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 06, 2018
Fed. Circ. Says On-Sale Bar May Invalidate Angiomax Patent
The Federal Circuit on Tuesday affirmed a district court's finding that Hospira doesn't infringe two blood thinner patents belonging to The Medicines Co., but remanded the question of whether The Medicines Co.'s distribution agreement with another company would render the patents invalid under the so-called on-sale bar.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login